Save information for later
Sign Up

Learn About Dystrophic Epidermolysis Bullosa

What is the definition of Dystrophic Epidermolysis Bullosa?

Dystrophic epidermolysis bullosa is one of the major forms of a group of conditions called epidermolysis bullosa. Epidermolysis bullosa cause the skin to be very fragile and to blister easily. Blisters and skin erosions form in response to minor injury or friction, such as rubbing or scratching. The signs and symptoms of dystrophic epidermolysis bullosa vary widely among affected individuals. In mild cases, blistering may primarily affect the hands, feet, knees, and elbows. Severe cases of this condition involve widespread blistering that can lead to vision loss, scarring, and other serious medical problems.

What are the causes of Dystrophic Epidermolysis Bullosa?

Mutations in the COL7A1 gene cause all forms of dystrophic epidermolysis bullosa. This gene provides instructions for making a protein that forms the pieces (subunits) of a larger protein called type VII collagen. Collagens are proteins that give structure and strength to connective tissues, such as skin, tendons, and ligaments, throughout the body. Type VII collagen plays an important role in strengthening and stabilizing the skin. It is the main component of structures called anchoring fibrils, which anchor the top layer of skin, called the epidermis, to an underlying layer called the dermis.

How prevalent is Dystrophic Epidermolysis Bullosa?

Considered together, the prevalence of recessive and dominant dystrophic epidermolysis bullosa is estimated to be 3.3 per million people.

Is Dystrophic Epidermolysis Bullosa an inherited disorder?

Recessive dystrophic epidermolysis bullosa (RDEB-sev gen and RDEB-gen and -loc) is inherited in an autosomal recessive pattern. Autosomal recessive inheritance means that both copies of the COL7A1 gene in each cell have mutations. Most often, the parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but do not show signs and symptoms of the condition.

Who are the top Dystrophic Epidermolysis Bullosa Local Doctors?
Jean Y. Tang
Elite in Dystrophic Epidermolysis Bullosa
Dermatology
Elite in Dystrophic Epidermolysis Bullosa
Dermatology

Stanford Health Care

420 Broadway St, 
Redwood City, CA 
Languages Spoken:
English

Jean Tang is a Dermatologist in Redwood City, California. Dr. Tang is rated as an Elite provider by MediFind in the treatment of Dystrophic Epidermolysis Bullosa. Her top areas of expertise are Basal Cell Skin Cancer, Nevoid Basal Cell Carcinoma Syndrome, Dystrophic Epidermolysis Bullosa, and Epidermolysis Bullosa.

Elite in Dystrophic Epidermolysis Bullosa
Elite in Dystrophic Epidermolysis Bullosa
13123 E 16th Ave, Children's Hospital Colorado, 
Aurora, CO 
Languages Spoken:
English
Accepting New Patients

Anna Bruckner is a Dermatologist in Aurora, Colorado. Dr. Bruckner is rated as an Elite provider by MediFind in the treatment of Dystrophic Epidermolysis Bullosa. Her top areas of expertise are Epidermolysis Bullosa, Dystrophic Epidermolysis Bullosa, Dominant Dystrophic Epidermolysis Bullosa, and Dowling-Meara Epidermolysis Bullosa Simplex. Dr. Bruckner is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Dystrophic Epidermolysis Bullosa
Elite in Dystrophic Epidermolysis Bullosa
Paris, FR 

Alain Hovnanian practices in Paris, France. Mr. Hovnanian is rated as an Elite expert by MediFind in the treatment of Dystrophic Epidermolysis Bullosa. His top areas of expertise are Netherton Syndrome, Dystrophic Epidermolysis Bullosa, Olmsted Syndrome, and Epidermolysis Bullosa.

What are the latest Dystrophic Epidermolysis Bullosa Clinical Trials?
Multi-centeR, Open-label Study to EValuate the Safety, Efficacy, and Pharmacokinetics of FIlsuVEz (Oleogel-S10) in Japanese Subjects With Epidermolysis Bullosa (REVIVE)

Summary: The goal of this clinical trial is to learn if Oleogel-S10 gel works to treat skin wounds from two types of inherited epidermolysis bullosa (EB): junctional EB (JEB) or dystrophic EB (DEB) in the Japanese population. Children and adults may participate. The trial also looks at the safety of Oleogel-S10 gel. The main questions it will answer are: * Does Oleogel-S10 gel close wounds from JEB or DEB ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Safety and Efficacy of Ev.FV in Epidermolysis Bullosa Patients, A Randomized Clinical Trial, Phase 1 , 2

Summary: Epidermolysis bullosa (EB) is a hereditary disease of skin tissues that causes painful bleeding blisters in the skin and mucous membrane. The prevalence of this disease is 1 in 50,000. The severity of the disease varies depending on the type of disease and may even lead to death. This disease is caused by a genetic mutation in keratin or collagen, and its incidence is the same in all men and women...

Who are the sources who wrote this article ?

Published Date: February 01, 2020
Published By: National Institutes of Health